<DOC>
	<DOCNO>NCT01130532</DOCNO>
	<brief_summary>The purpose trial evaluate treatment tadalafil daily allow men return normal erectile function normal erectile function follow as-needed ( PRN ) Phosphodiesterase Type 5 ( PDE5 ) Inhibitor treatment .</brief_summary>
	<brief_title>A Study Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>At least 3month history erectile dysfunction ( ED ) . Are able read , understand provide sign informed consent . Have International Index Erectile FunctionErectile Function ( IIEFEF ) domain score great equal 17 less 26 screening . Have take maximum dose sildenafil citrate ( 100 milligram [ mg ] ) , vardenafil ( 20 mg ) , tadalafil ( 20 mg ) need basis least one month prior screen . Anticipate female sexual partner study willing participate require number sexual intercourse attempt complete study measure study . Agree make least four sexual intercourse attempt 4week need runin period 4week nondrug runin period . Agree use erectile dysfunction ( ED ) treatment , include herbal therapy 4week nondrug , runin , doubleblind treatment period , open label period 96 hour end study . Partner Are female least 18 year age screening . Anticipate male study subject sexual partner study . Able read , understand provide sign informed consent . Agree make require number sexual intercourse attempt male sexual study partner study . Willing participate recording response treatment satisfaction scale . Have IIEFEF domain score great equal 26 screening . Prior ineffective treatment ( nonresponder ) PDE5 Inhibitor Have previously use currently use PDE5 inhibitor daily . Present ED cause primary disorder ED cause untreated/inadequately treated endocrine disease . Partner unwilling complete study requirement . History radical prostatectomy pelvic surgery penile implant , clinically significant penile deformity , opinion investigator Exhibit evidence clinically significant renal insufficiency hepatobiliary disease , significant cardiac history determine investigator Currently receive treatment nitrate , cancer chemotherapy , antiandrogens Have previously complete withdrawn study study investigate tadalafil oncedaily use .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>ED</keyword>
	<keyword>Impotence</keyword>
</DOC>